As of 2024-12-11, the Relative Valuation of Pfizer Inc (PFE) is 17.09 USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.57 USD, the upside of Pfizer Inc based on Relative Valuation is -33.2%.
The range of the Relative Valuation is 8.99 - 24.81 USD.
| Range | Selected | |
| Trailing P/E multiples | 29.5x - 33.1x | 31.4x |
| Forward P/E multiples | 27.6x - 38.8x | 32.6x |
| Fair Price | 8.99 - 24.81 | 17.09 |
| Upside | -64.8% - -3.0% | -33.2% |
| Date | P/E |
| 2024-12-09 | 34.79 |
| 2024-12-06 | 34.29 |
| 2024-12-05 | 34.25 |
| 2024-12-04 | 33.63 |
| 2024-12-03 | 34.07 |
| 2024-12-02 | 34.41 |
| 2024-11-29 | 34.93 |
| 2024-11-27 | 34.43 |
| 2024-11-26 | 34.35 |
| 2024-11-25 | 34.88 |
| 2024-11-22 | 34.19 |
| 2024-11-21 | 33.49 |
| 2024-11-20 | 33.24 |
| 2024-11-19 | 33.45 |
| 2024-11-18 | 33.13 |
| 2024-11-15 | 33.05 |
| 2024-11-14 | 34.68 |
| 2024-11-13 | 35.61 |
| 2024-11-12 | 34.91 |
| 2024-11-11 | 34.97 |
| 2024-11-08 | 35.61 |
| 2024-11-07 | 36.60 |
| 2024-11-06 | 36.46 |
| 2024-11-05 | 37.30 |
| 2024-11-04 | 37.00 |
| 2024-11-01 | 37.44 |
| 2024-10-31 | 37.72 |
| 2024-10-30 | 38.01 |
| 2024-10-29 | 37.93 |
| 2024-10-28 | 38.46 |
| 2024-10-25 | 37.92 |
| 2024-10-24 | 38.17 |
| 2024-10-23 | 38.46 |
| 2024-10-22 | 38.44 |
| 2024-10-21 | 38.56 |
| 2024-10-18 | 38.94 |
| 2024-10-17 | 39.01 |
| 2024-10-16 | 39.54 |
| 2024-10-15 | 39.24 |
| 2024-10-14 | 38.76 |
| 2024-10-11 | 38.86 |
| 2024-10-10 | 39.10 |
| 2024-10-09 | 40.24 |
| 2024-10-08 | 38.89 |
| 2024-10-07 | 38.92 |
| 2024-10-04 | 38.09 |
| 2024-10-03 | 37.77 |
| 2024-10-02 | 38.13 |
| 2024-10-01 | 38.21 |
| 2024-09-30 | 38.57 |